Morphosys - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Morphosys to enrol more patients in tafasitamab’s B-MIND trial

Morphosys
MorphoSys expects to report top-line data from the B-MIND trial in 2022. Credit: MorphoSys AG.